Skip to content

PHARMASIMPLE

Open bankruptcy
Public limited companyfounded 2012Rue Adolphe Quételet sn, 7180 Seneffe, BelgiumKBO/BCE: BE 0845.603.735
Summary

A bankruptcy procedure is open for PHARMASIMPLE according to publications in the Belgian State Gazette. The 2021 annual accounts show equity of €4.1m and a net result of -€8.9m.

PHARMASIMPLEOpen bankruptcy

Are you a creditor?

Open bankruptcy Source: Belgian Official Gazette

If this company owes you money, you are not paid automatically: you file your claim yourself, within the deadline the judgment sets.

The procedure

Court
Enterprise Court of Hainaut, Charleroi division
Declared bankrupt
19 June 2023
Supervising judge
Alberto Munoz Y Moles
Official Gazette
23-06-2023 (pdf) ↗search the document for 2023/125156

Deadlines

Provisional date payments stopped
19 June 2023A later judgment can change the date.art. XX.105 CEL
Appeal or third-party opposition until
passed on 8 July 2023Fifteen days after the publication in the Official Gazette.art. XX.108 CEL
File the claim in RegSol until
passed on 19 July 2023art. XX.104 and XX.155 CEL
First verification report
passed on 16 August 2023Goods that belong to you, such as those delivered under retention of title, are reclaimed before this day.art. XX.104 and XX.194 CEL
Late claim until
passed on 19 June 2024Late, you share only in what has not been paid out yet, and the costs are yours.art. XX.165 CEL

Curators

  • Isabelle BronkaertChaussee De Thuin 164, 6032 Mont-Sur-Marchienneavocat.bronkaert@bbaasrl.be
  • Pierre-Emmanuel CornilRue De Gozee, 137, 6110 Montigny-Le-Tilleul- . Date provisoire de cessation de paiement : 19/06/2023pe.cornil@codeca.be

What to do now

  1. Do not deliver on credit any more without an agreement with the curator.
  2. Gather your documents: invoices, purchase orders, contract, delivery notes and reminders.
  3. File your proof of claim in RegSol (regsol.be), yourself with eID or itsme, or through your lawyer. State principal, interest and costs separately, and any preferential right you hold.
  4. Delivered under retention of title? Reclaim your goods before the first report on the verification of claims.
  5. Ask your accountant about the VAT on the unpaid invoices: in a bankruptcy it can be recovered under conditions.
  6. Follow the file in RegSol: the verification report (admitted or disputed) and the curator's reports appear there.

The deadlines above come from the publication of the judgment. Check them in RegSol before you file anything; a passed deadline no longer applies.

File a claim in RegSol ↗ Watch Follow this bankruptcy: you are alerted when it is closed or reversed.

General information, not legal advice. If in doubt, the curator, your lawyer or your accountant can help.Creditor guide for this company

Embed in an article

Writing about this bankruptcy? Put the card of PHARMASIMPLE in your article: name, enterprise number, its status in the KBO and the latest annual accounts, with a link to this dossier.

Preview
The preview appears here.
  • Stays current: the status follows the register, the figures are those of the latest filed accounts. No Checked score or verdict.
  • Light on your page: one small script and one data request, also answered from a cache; no cookies, no tracking.
  • Where scripts do not run (a newsletter, a feed reader) a plain link remains.

Signals

Three signals. The signal on the left, the evidence on the right.
+raises risk○neutral
raises risk · Register: open bankruptcy
The KBO register records the legal situation: open bankruptcy. This is today's state according to the register itself; the register carries no start date.
KBO · legal situation
raises risk · Open bankruptcy
Active bankruptcy procedure in the Belgisch Staatsblad. Claims are handled by the appointed curator.
Belgian State Gazette
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2021 was due by 31-07-2022 and was filed on 02-06-2022, 59 days ahead of the deadline.
NBB · 9 filings
Deviation from the deadline
2025
not confirmed
2024
not filed
2023
not filed
2022
not filed
2021
59 d early
2020
39 d late
2019
31 d early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 3 accounts on average 17 days before the deadline; the sector median for financial year 2024 is on the deadline day, and 47% of the sector filed late.

Checked, nothing found (1)
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

PHARMASIMPLE was incorporated on 27 April 2012.1 Revenue grew from EUR 16 million in 2018 to EUR 30 million in 2021 and headcount from 32.7 to 57.9 full-time equivalents.2 On 19 June 2023 the company was declared bankrupt.3

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2018 and 2021
  3. 3Belgian State Gazette, 23-06-2023

Go further with this company

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2021, full schema

Turnover
€29.9m▼ 31.4%
2020 · €43.6m
EBIT margin
-28.6%▼ 28.3pp
2020 · -0.3%
Net result
-€8.9m▼ 3,036%
2020 · -€285,010
Working capital
€1.1m▼ 73.0%
2020 · €4.1m
Trend over the years

Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 47, Retail trade, each year against the same schema; no band under 30 filings. Dashed line: the median.

Every figure with its change against the fiscal year before
favourable unfavourable
Line2018201920202021
Turnover€16.2m-€24.8m▲ 53.6%€43.6m▲ 75.5%€29.9m▼ 31.4%
Operating result-€2.1m--€1.8m▲ 17.8%-€146,747▲ 91.6%-€8.6m▼ 5,728%
Net result-€2.2m--€1.9m▲ 16.1%-€285,010below the sector's middle half▲ 84.8%-€8.9mbelow the sector's middle half▼ 3,036%
EBIT margin-13.2%--7.1%▲ 6.1pp-0.3%▲ 6.7pp-28.6%▼ 28.3pp
Equity€2.0m-€8.4m▲ 318%€8.2mabove the sector's middle half▼ 2.9%€4.1mabove the sector's middle half▼ 49.3%
Total assets€9.8m-€20.9m▲ 114%€24.1mabove the sector's middle half▲ 15.4%€18.2mabove the sector's middle half▼ 24.6%
Debt€7.7m-€12.5m▲ 61.3%€16.0m▲ 27.7%€14.0m▼ 12.0%
Working capital€571,549-€4.3m▲ 661%€4.1mabove the sector's middle half▼ 6.2%€1.1mabove the sector's middle half▼ 73.0%
Solvency20.7%-40.3%▲ 19.6pp33.9%within the sector's middle half▼ 6.4pp22.8%within the sector's middle half▼ 11.1pp
Current ratio1.09-1.57▲ 0.481.36within the sector's middle half▼ 0.211.13within the sector's middle half▼ 0.23
Return on assets (ROA)-22.9%--9.0%▲ 13.9pp-1.2%below the sector's middle half▲ 7.8pp-49.1%below the sector's middle half▼ 47.9pp
Staff (FTE)32.7-39.6▲ 21.1%49.8above the sector's middle half▲ 25.8%57.9above the sector's middle half▲ 16.3%
above within below the middle half (P25 to P75) of NACE 47, Retail trade, each year against the same schema; no band under 30 filings.
Result per fiscal year
Operating resultNet result
-€10.0m-€7.5m-€5.0m-€2.5m€0Operating result 2018: -€2.1m-€2.1mNet result 2018: -€2.2m-€2.2mOperating result 2019: -€1.8m-€1.8mNet result 2019: -€1.9m-€1.9mOperating result 2020: -€146,747-€146,747Net result 2020: -€285,010-€285,010Operating result 2021: -€8.6m-€8.6mNet result 2021: -€8.9m-€8.9m2018201920202021-€10m-€7.5m-€5m-€2.5m€0Operating result 2019: -€1.8m-€1.8mNet result 2019: -€1.9m-€1.9mOperating result 2020: -€146,747-€147,000Net result 2020: -€285,010-€285,000Operating result 2021: -€8.6m-€8.6mNet result 2021: -€8.9m-€8.9m201920202021
The operating result stays negative: a loss of €8.6m in 2021 against €146,747 in 2020; the loss grows and 2021 has the lowest result in the available series.
Balance-sheet composition
2021 in colour, 2020 as the grey bar beneath
Assets €18.0m
Fixed assets €8.4m ▼ 1.0%
Current assets €9.6m ▼ 37.5%
Equity and liabilities €18.2m
Equity €4.1m ▼ 49.3%
Debt €14.0m ▼ 12.0%
Debt's share of the balance-sheet total rises from 66.1% to 77.2%. Equity and debt are lower.
Key figures and ratios
2021 value · change against 2020
EBITDA
-€7.6m▼
2020 · €727,752
Cash flow
-€8.0m▼
2020 · €589,489
Quick ratio
0.76▼
2020 · 0.92
Debt to equity
3.39▲
2020 · 0.57
ROE
-215.6%▼
2020 · -3.5%
Interest coverage
-22.52▼
2020 · 7.00
Debt ≤ 1 year
€8.5m▼
2020 · €11.3m
Debt > 1 year
€5.5m▲
2020 · €4.7m
Income taxes
€1,416
Staff costs
€3.4m
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
Filed annual accounts As filed with the NBB · 2021 against 2020 · 78 lines
Balance sheet Code20202021
Assets
Total assets20/58€24.1m€18.2m▼
Formation expenses20€277,893€160,710▼
Fixed assets21/28€8.5m€8.4m▼
Intangible fixed assets21€1.1m€1.0m▼
Tangible fixed assets22/27€326,750€267,733▼
Plant, machinery and equipment23-€31,966
Furniture and vehicles24-€26,123
Leasing and similar rights25-€16,352
Other tangible fixed assets26-€193,292
Financial fixed assets28€7.1m€7.1m=
Affiliated companies280/1-€7.1m
Participating interests280-€7.1m
Other financial fixed assets284/8-€2,600
Amounts receivable and cash guarantees285/8-€2,600
Current assets29/58€15.3m€9.6m▼
Stocks and contracts in progress3€5.0m€3.1m▼
Stocks30/36-€3.1m
Goods purchased for resale34-€3.1m
Amounts receivable within one year40/41€7.0m€5.2m▼
Trade receivables40-€4.6m
Other amounts receivable41-€641,447
Cash at bank and in hand54/58€3.3m€1.1m▼
Deferred charges and accrued income490/1-€109,037
Equity and liabilities
Total equity and liabilities10/49€24.1m€18.2m▼
Equity10/15€8.2m€4.1m▼
Contributions10/11€8.0m€15.2m▲
Capital10-€12.9m
Issued capital100-€12.9m
Outside capital11-€2.4m
Share premium1100/10-€2.4m
Profit (loss) carried forward14-€2.2m-€11.1m▼
Amounts payable17/49€16.0m€14.0m▼
Amounts payable after more than one year17€4.7m€5.5m▲
Financial debts170/4-€4.7m
Unsubordinated bonds171-€4.3m
Leasing and similar obligations172-€3,535
Credit institutions173-€408,750
Other amounts payable178/9-€823,810
Amounts payable within one year42/48€11.3m€8.5m▼
Current portion of amounts payable after more than one year42-€1.1m
Financial debts43-€3.2m
Credit institutions430/8-€3.2m
Trade debts44€6.9m€3.9m▼
Suppliers440/4-€3.9m
Taxes, remuneration and social security45-€313,469
Taxes450/3-€99,651
Remuneration and social security454/9-€213,818
Accrued charges and deferred income492/3-€42,613
Income statement Code20202021
Operating income70/76A-€31.8m
Turnover70€43.6m€29.9m▼
Own construction capitalised72-€408,964
Other operating income74-€1.5m
Operating charges60/66A-€40.3m
Goods for resale, raw materials and consumables60-€26.6m
Purchases600/8-€25.5m
Change in stocks: decrease (increase)609-€1.1m
Services and other goods61-€6.0m
Remuneration, social security and pensions62-€3.4m
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€874,500€912,376▲
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4-€3.1m
Other operating charges640/8-€139,564
Non-recurring operating charges66A-€283,668
Operating profit (loss)9901-€146,747-€8.6m▼
Financial income75/76B-€95
Recurring financial income75€963€95▼
Other financial income752/9-€95
Financial charges65/66B-€382,910
Recurring financial charges65€139,226€382,910▲
Debt charges650€103,944€339,257▲
Other financial charges652/9-€43,653
Profit (loss) for the period before taxes9903-€285,010-€8.9m▼
Income taxes67/77-€1,416
Taxes670/3-€1,416
Profit (loss) for the period9904-€285,010-€8.9m▼
Profit (loss) for the period to be appropriated9905-€285,010-€8.9m▼
Appropriation of the result
Profit (loss) to be appropriated9906--€11.1m
Profit (loss) brought forward from the previous period14P--€2.2m
Social balance
Average headcount (FTE)9087-57.9

The notes to these accounts (82 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line2018201920202021Change
Operating income70/76A---€31.8m-
Turnover70€16.2m€24.8m€43.6m€29.9m▼ 31.4%
Own construction capitalised72---€408,964-
Other operating income74---€1.5m-
Operating charges60/66A---€40.3m-
Goods for resale, raw materials and consumables60---€26.6m-
Purchases600/8---€25.5m-
Change in stocks: decrease (increase)609---€1.1m-
Services and other goods61---€6.0m-
Remuneration, social security and pensions62---€3.4m-
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€514,920€740,096€874,500€912,376▲ 4.3%
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4---€3.1m-
Other operating charges640/8---€139,564-
Non-recurring operating charges66A---€283,668-
Operating profit (loss)9901-€2.1m-€1.8m-€146,747-€8.6m▼ 5,728%
Financial income75/76B---€95-
Recurring financial income75€142€1,434€963€95▼ 90.2%
Other financial income752/9---€95-
Financial charges65/66B---€382,910-
Recurring financial charges65€100,770€121,084€139,226€382,910▲ 175%
Debt charges650€82,533€102,421€103,944€339,257▲ 226%
Other financial charges652/9---€43,653-
Profit (loss) for the period before taxes9903-€2.2m-€1.9m-€285,010-€8.9m▼ 3,035%
Income taxes67/77€865€1,324-€1,416-
Taxes670/3---€1,416-
Profit (loss) for the period9904-€2.2m-€1.9m-€285,010-€8.9m▼ 3,036%
Profit (loss) for the period to be appropriated9905-€2.2m-€1.9m-€285,010-€8.9m▼ 3,036%
Line2018201920202021Change
Assets
Total assets20/58€9.8m€20.9m€24.1m€18.2m▼ 24.6%
Formation expenses20€316,120€401,520€277,893€160,710▼ 42.2%
Fixed assets21/28€2.5m€8.6m€8.5m€8.4m▼ 1.0%
Intangible fixed assets21€1.0m€1.1m€1.1m€1.0m▼ 2.4%
Tangible fixed assets22/27€490,669€386,720€326,750€267,733▼ 18.1%
Plant, machinery and equipment23---€31,966-
Furniture and vehicles24---€26,123-
Leasing and similar rights25---€16,352-
Other tangible fixed assets26---€193,292-
Financial fixed assets28€1.0m€7.1m€7.1m€7.1m=
Affiliated companies280/1---€7.1m-
Participating interests280---€7.1m-
Other financial fixed assets284/8---€2,600-
Amounts receivable and cash guarantees285/8---€2,600-
Current assets29/58€6.9m€11.9m€15.3m€9.6m▼ 37.5%
Stocks and contracts in progress3€3.5m€4.6m€5.0m€3.1m▼ 36.7%
Stocks30/36---€3.1m-
Goods purchased for resale34---€3.1m-
Amounts receivable within one year40/41€1.5m€2.8m€7.0m€5.2m▼ 25.0%
Trade receivables40---€4.6m-
Other amounts receivable41---€641,447-
Cash at bank and in hand54/58€1.9m€4.2m€3.3m€1.1m▼ 65.8%
Deferred charges and accrued income490/1---€109,037-
Equity and liabilities
Total equity and liabilities10/49€9.8m€20.9m€24.1m€18.2m▼ 24.6%
Equity10/15€2.0m€8.4m€8.2m€4.1m▼ 49.3%
Contributions10/11€7.0m€8.0m€8.0m€15.2m▲ 90.7%
Capital10---€12.9m-
Issued capital100---€12.9m-
Outside capital11---€2.4m-
Share premium1100/10---€2.4m-
Profit (loss) carried forward14-€5.0m-€1.9m-€2.2m-€11.1m▼ 413%
Amounts payable17/49€7.7m€12.5m€16.0m€14.0m▼ 12.0%
Amounts payable after more than one year17€1.4m€4.8m€4.7m€5.5m▲ 17.6%
Financial debts170/4---€4.7m-
Unsubordinated bonds171---€4.3m-
Leasing and similar obligations172---€3,535-
Credit institutions173---€408,750-
Other amounts payable178/9---€823,810-
Amounts payable within one year42/48€6.4m€7.6m€11.3m€8.5m▼ 24.6%
Current portion of amounts payable after more than one year42---€1.1m-
Financial debts43---€3.2m-
Credit institutions430/8---€3.2m-
Trade debts44€3.1m€4.7m€6.9m€3.9m▼ 43.6%
Suppliers440/4---€3.9m-
Taxes, remuneration and social security45---€313,469-
Taxes450/3---€99,651-
Remuneration and social security454/9---€213,818-
Accrued charges and deferred income492/3---€42,613-
Line2018201920202021Change
Profit (loss) for the period9904-€2.2m-€1.9m-€285,010-€8.9m▼ 3,036%
+ Depreciation and write-downs630€514,920€740,096€874,500€912,376▲ 4.3%
Operating cash flow (approximation)-€1.7m-€1.1m€589,489-€8.0m▼ 1,461%
Investment in fixed assets (approximation)--€6.8m-€813,918-€827,310▼ 1.6%
Change in cash-€2.4m-€976,208-€2.1m▼ 120%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

2023
23-06
Bankruptcy Opening
Tribunal de l’entreprise du Hainaut, division Charleroi · event 19-06-2023
2022
02-06
NBB filing Annual accounts filed
fiscal year 2021 · full schema
2021
31-12
Financial Weakest financial yearnet -€8.9m
Net result drops to -€8.9m, the lowest in the series.
08-09
NBB filing Annual accounts filed
fiscal year 2020 · full schema · 39 days late
2020
30-06
NBB filing Annual accounts filed
fiscal year 2019 · full schema
2019
31-12
Financial Equity above €5mEq €8.4m ▲318%
Equity rises from €2.0m to €8.4m.
14-06
NBB filing Annual accounts filed
fiscal year 2018 · full schema
2018
20-07
NBB filing Annual accounts filed
fiscal year 2017 · full schema
2017
30-06
NBB filing Annual accounts filed
fiscal year 2016 · full schema
2016
11-07
NBB filing Annual accounts filed
fiscal year 2015 · full schema
2015
30-06
NBB filing Annual accounts filed
fiscal year 2014 · full schema
28-01
NBB filing Annual accounts filed
fiscal year 2013 · full schema · 181 days late
SignalFinancial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 52 acts read
About the unread acts

We know of 52 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
52 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Seneffe · 1 establishment unit since 2018
seat establishment approximate The establishment unit on the map
Ground area
5.1 ha
Building footprint
1,605 m²
Volume, LiDAR
10,324 m³
Parcel 52063E0154/00D000, Wallonia · tallest building 7.8 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
PHARMASIMPLE
Rue Adolphe Quételet sn, 7180 SeneffeRetail trade
since 20182.271.808.492
1 parcel
Wallonia 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
52063E0154/00D000 Wallonia 5.1 ha 1 · 1,605 m² 7.8 m · 2 fl.
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Insolvency mandates

2 mandates
Role Name Tenure
Curator ISABELLE BRONKAERT
CHAUSSEE DE THUIN 164, 6032 MONT-SUR-MARCHIENNE
19-06-2023 → present
Curator PIERRE-EMMANUEL CORNIL
RUE DE GOZEE, 137, 6110 MONTIGNY-LE-TILLEUL- . Date provisoire de cessation de paiement : 19/06/2023
19-06-2023 → present

Structure & network

Owners and holdings

1 owner · 3 holdings

Owners 1

Holdings 3

According to the 2021 annual accounts of PHARMASIMPLE and those of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.

Connections & network

No current directors or connected companies found in the register.

Recognitions · licences · registrations

Legal Entity Identifier

549300YPXP612OZP5394
no longer live in the LEI register

Similar companies · same sector, comparable size

Of 12,951 companies in sector 47120 we hold annual accounts for 2,192. 417 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Identification & contact

Identification
Legal formPublic limited company
Founded27-04-2012
Fiscal year end31-12
Activities, NACEBEL 2025
47120Other non-specialised retail sale
Contact
Phone 0496397757
E-invoicing
Not found in the Peppol register

No Peppol card under this enterprise or VAT number. That proves nothing: publishing a card is voluntary.

Register as of 29 September 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.

General meetings

12 convocations
Extraordinary general meeting
on 07-11-2022 at 16u · published 12-10-2022
Agenda
de cette l’assemblée générale extraordinaire sera le suivant : 1. Prise de connaissance de la démission de M. Harold Lanoy et M. Didier Pêtre en tant qu’administrateur de la Société et confirmation du mandat d’administrateur de la société Chamaga. Proposition de décision : L’assemblée générale prend connaissance des démissions de M. Harold Lannoy et M. Didier Pêtre en tant qu’administrateur de la Société, avec effet respectivement au 27 juin 2022 et 8 septembre 2022. L’assemblée générale décide de confirmer le mandat d’administra- teur octroyé à la société Chamaga, une société à responsabilité limitée (SRL) dont le siège est situé avenue Belle Vue 21, à 1310 La Hulpe, enregistrée à la Banque ...
Extraordinary general meeting
on 27-05-2022 at 14u · published 12-05-2022
Agenda
de l’assemblée sera le suivant : 1. Procédure visée par l’article 7:228 du Code des sociétés et associations : lecture et discussion du rapport spécial du conseil d’administration et approbation des mesures proposées par le conseil d’administration afin d’assurer la continuité de la Société Proposition de décision : Les actionnaires examinent le rapport spécial du conseil d’administration rédigé conformément à l’article 7:228 du Code des sociétés et associations et les mesures proposées par le Conseil d’Administration
Extraordinary general meeting
on 22-09-2021 at 11u · published 06-09-2021
Agenda
de l’assemblée générale extraordinaire : Emission d’obligations convertibles 1. Prise de connaissance des rapports suivants : a. du conseil d’administration concernant : i. l’émission des obligations convertibles, établi conformément aux articles 7:180, 7:191 et 7:193 du Code des sociétés et des associations exposant (i) la justification de l’opération proposée, ainsi que la justification du prix d’émission (prix de conversion) (ii) les raisons de la suppression du droit de préférence au profit de « Global TECH Opportunities 12 », une société des îles Caïmans (ci-après « l’Investisseur ») ainsi que (iii) la description des conséquences de l’opération sur les droits patrimoniaux et sociaux de ...
Ordinary general meeting
on 28-05-2021 at 14u · published 11-05-2021
de l’assemblée générale ordinaire : 1. Prise de connaissance et discussion des comptes annuels, statutaires et consolidés,
Extraordinary general meeting
on 27-01-2021 at 17u · published 17-01-2022
Agenda
de cette l’assemblée générale extraordinaire sera le suivant : 1. Exposé du Président et prise de connaissance du rapport spécial du conseil d’administration concernant les circonstances spécifiques dans lesquelles le capital autorisé pourra être utilisé et les objectifs poursuivis, établi en application de l’article 7 :199 du Code des sociétés et des associations Proposition de décision : non-applicable. 2. Autorisation en matière de capital autorisé Proposition de décision : L’assemblée générale décide d’approuver la proposition du conseil d’administration en matière de capital autorisé et plus précisément autorise le conseil d’administration à procéder aux opérations suivantes par la voie ...
Show 7 more convocations
Extraordinary general meeting
on 06-01-2021 at 17u · published 27-12-2021
Agenda
de cette l’assemblée générale extraordinaire sera le suivant : 1. Exposé du Président et prise de connaissance du rapport spécial du conseil d’administration concernant les circonstances spécifiques dans lesquelles le capital autorisé pourra être utilisé et les objectifs poursuivis, établi en application de l’article 7 :199 du Code des sociétés et des associations Proposition de décision : non-applicable. 2. Autorisation en matière de capital autorisé Proposition de décision : L’assemblée générale décide d’approuver la proposition du conseil d’administration en matière de capital autorisé et plus précisément autorise le conseil d’administration à procéder aux opérations suivantes par la voie ...
Ordinary general meeting
on 29-05-2020 at 14u · published 14-05-2020
de l’assemblée générale ordinaire : 1. Prise de connaissance et discussion des comptes annuels, statutaires et consolidés,
Extraordinary general meeting
on 31-03-2020 at 15u · published 13-03-2020
Agenda
de l’assemblée générale extraordinaire : 1. Prise de connaissance du rapport du conseil d’administration concernant l’émission de droits de souscription (dans le cadre d’un plan de stock-options), établi conformément aux articles 7 :191 juncto 7 :180 du Code des sociétés et des associations. 2. Prise de connaissance du rapport du commissaire, établi conformément aux articles 7 :191 juncto 7 :180 du Code des sociétés et des associations. 3. Suppression du droit de préférence à l’occasion de l’émission des droits de souscription, au profit des bénéficiaires du plan de stock- option. 4. Emission de 144.000 droits de souscription (dans le cadre d’un plan de stock-options), tel que déterminée dan ...
Extraordinary general meeting
on 27-09-2019 at 17u · published 13-09-2019
Agenda
, pourra valablement délibérer, quelle que soit la part du capital représentée. Ordre du jour de l’assemblée générale extraordinaire : 1. Réduction du capital social par apurement des pertes, conformé- ment à l’article 614 du Code des sociétés, à concurrence d’un montant de 5.011.453,56 EUR,
Ordinary general meeting
on 31-05-2019 at 14u · published 16-05-2019
de l’assemblée générale ordinaire : 1. Prise de connaissance et discussion des comptes annuels, statutaires et consolidés,
Extraordinary general meeting
on 14-03-2019 at 14u · published 27-02-2019
Agenda
est le suivant : Documents 1. Prise de connaissance des rapports suivants : Rapport du conseil d’administration, établi conformément à l’article 602, § 1 du Code des sociétés, portant sur l’intérêt
Extraordinary general meeting
on 31-10-2018 at 15u · published 15-10-2018
Agenda
de l’assemblée générale extraordinaire : 1. Ratification de la décision du conseil d’administration de transférer le siège social à 7110 Houdeng-Goegnies, boulevard Millenium 11, et modification de l’article 2 des statuts